Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Pollock

Showing results (291-300 of 327) with videos related to

Pageof 33
Sort By:
The American Journal of Psychiatry|April 2, 2016
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD StudyAnne K Leonpacher, Matthew E Peters, Lea T Drye, et al.
Plos One|June 11, 2014
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trialLea T Drye, David Spragg, D P Devanand, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 5, 2015
Time to Response to Citalopram Treatment for Agitation in Alzheimer DiseaseDaniel Weintraub, Lea T Drye, Anton P Porsteinsson, et al.
Cognitive Neurodynamics|June 3, 2024
Neurophysiological and other features of working memory in older adults at risk for dementiaRachel A Patterson, Heather Brooks, Mina Mirjalili, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsSena Gok, Salma Amarin, Nicole Schoer, et al.
International Psychogeriatrics|August 26, 2015
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialPaul B Rosenberg, Lea T Drye, Anton P Porsteinsson, et al.
Journal of Alzheimer'S Disease : JAD|June 23, 2020
Design and Rationale of the PACt-MD Randomized Clinical Trial: Prevention of Alzheimer's dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment and DepressionTarek K Rajji, Christopher R Bowie, Nathan Herrmann, et al.
The American Journal of Psychiatry|January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialLon S Schneider, Constantine Frangakis, Lea T Drye, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 27, 2026
Brain Structures and Cognitive Decline: Moderation Analysis of the PACt-MD Randomized Clinical Trial of Brain Stimulation Plus Cognitive Remediation in Older Adults With Remitted Depression or Mild Cognitive ImpairmentNatalie C W Ho, Peter Zhukovsky, Tarek K Rajji, et al.
Psychiatric Services (Washington, D.C.)|July 1, 2009
Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patientsDavid J Kupfer, David A Axelson, Boris Birmaher, et al.
Pageof 33

Showing results (291-300 of 327) with videos related to

Sort By:
Pageof 33
The American Journal of Psychiatry|April 2, 2016
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD StudyAnne K Leonpacher, Matthew E Peters, Lea T Drye, et al.
Plos One|June 11, 2014
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trialLea T Drye, David Spragg, D P Devanand, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 5, 2015
Time to Response to Citalopram Treatment for Agitation in Alzheimer DiseaseDaniel Weintraub, Lea T Drye, Anton P Porsteinsson, et al.
Cognitive Neurodynamics|June 3, 2024
Neurophysiological and other features of working memory in older adults at risk for dementiaRachel A Patterson, Heather Brooks, Mina Mirjalili, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsSena Gok, Salma Amarin, Nicole Schoer, et al.
International Psychogeriatrics|August 26, 2015
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialPaul B Rosenberg, Lea T Drye, Anton P Porsteinsson, et al.
Journal of Alzheimer'S Disease : JAD|June 23, 2020
Design and Rationale of the PACt-MD Randomized Clinical Trial: Prevention of Alzheimer's dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment and DepressionTarek K Rajji, Christopher R Bowie, Nathan Herrmann, et al.
The American Journal of Psychiatry|January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialLon S Schneider, Constantine Frangakis, Lea T Drye, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 27, 2026
Brain Structures and Cognitive Decline: Moderation Analysis of the PACt-MD Randomized Clinical Trial of Brain Stimulation Plus Cognitive Remediation in Older Adults With Remitted Depression or Mild Cognitive ImpairmentNatalie C W Ho, Peter Zhukovsky, Tarek K Rajji, et al.
Psychiatric Services (Washington, D.C.)|July 1, 2009
Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patientsDavid J Kupfer, David A Axelson, Boris Birmaher, et al.
Pageof 33